Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17560278rdf:typepubmed:Citationlld:pubmed
pubmed-article:17560278lifeskim:mentionsumls-concept:C0205102lld:lifeskim
pubmed-article:17560278lifeskim:mentionsumls-concept:C0021027lld:lifeskim
pubmed-article:17560278lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:17560278lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:17560278lifeskim:mentionsumls-concept:C2248928lld:lifeskim
pubmed-article:17560278pubmed:dateCreated2007-6-11lld:pubmed
pubmed-article:17560278pubmed:abstractTextB-cell intrinsic immunoglobulin class switch recombination (Ig-CSR) deficiencies, previously termed hyper-IgM syndromes, are genetically determined conditions characterized by normal or elevated serum IgM levels and an absence or very low levels of IgG, IgA, and IgE. As a function of the molecular mechanism, the defective CSR is variably associated to a defect in the generation of somatic hypermutations (SHMs) in the Ig variable region. The study of Ig-CSR deficiencies contributed to a better delineation of the mechanisms underlying CSR and SHM, the major events of antigen-triggered antibody maturation. Four Ig-CSR deficiency phenotypes have been so far reported: the description of the activation-induced cytidine deaminase (AID) deficiency (Ig-CSR deficiency 1), caused by recessive mutations of AICDA gene, characterized by a defect in CSR and SHM, clearly established the role of AID in the induction of the Ig gene rearrangements underlying CSR and SHM. A CSR-specific function of AID has, however, been detected by the observation of a selective CSR defect caused by mutations affecting the C-terminus of AID. Ig-CSR deficiency 2 is the consequence of uracil-N-glycosylase (UNG) deficiency. Because UNG, a molecule of the base excision repair machinery, removes uracils from DNA and AID deaminates cytosines into uracils, that observation indicates that the AID-UNG pathway directly targets DNA of switch regions from the Ig heavy-chain locus to induce the CSR process. Ig-CSR deficiencies 3 and 4 are characterized by a selective CSR defect resulting from blocks at distinct steps of CSR. A further understanding of the CSR machinery is expected from their molecular definition.lld:pubmed
pubmed-article:17560278pubmed:languageenglld:pubmed
pubmed-article:17560278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17560278pubmed:citationSubsetIMlld:pubmed
pubmed-article:17560278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17560278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17560278pubmed:statusMEDLINElld:pubmed
pubmed-article:17560278pubmed:issn0065-2776lld:pubmed
pubmed-article:17560278pubmed:authorpubmed-author:FischerAlainAlld:pubmed
pubmed-article:17560278pubmed:authorpubmed-author:DurandyAnneAlld:pubmed
pubmed-article:17560278pubmed:authorpubmed-author:TaubenheimNad...lld:pubmed
pubmed-article:17560278pubmed:authorpubmed-author:PeronSophieSlld:pubmed
pubmed-article:17560278pubmed:issnTypePrintlld:pubmed
pubmed-article:17560278pubmed:volume94lld:pubmed
pubmed-article:17560278pubmed:ownerNLMlld:pubmed
pubmed-article:17560278pubmed:authorsCompleteYlld:pubmed
pubmed-article:17560278pubmed:pagination275-306lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:meshHeadingpubmed-meshheading:17560278...lld:pubmed
pubmed-article:17560278pubmed:year2007lld:pubmed
pubmed-article:17560278pubmed:articleTitlePathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.lld:pubmed
pubmed-article:17560278pubmed:affiliationInserm, U768, Paris F-75015, France.lld:pubmed
pubmed-article:17560278pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17560278pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17560278pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17560278lld:pubmed